Cornerstone Robotics Partners with Medtronic to Enhance Access to Robotic-Assisted Surgery

Cornerstone Robotics and Medtronic Unite for Global Healthcare Access

In a groundbreaking announcement, Cornerstone Robotics, an innovative surgical robotics firm based in Hong Kong, has formed a significant partnership with Medtronic, a global leader in healthcare technology. This collaboration aims to broaden access to robotic-assisted surgery, which remains underutilized worldwide despite the enormous potential for enhanced patient care. Medtronic's strategic investment of approximately $700 million into Cornerstone Robotics signifies a deep commitment to reshaping the surgical landscape.

The Vision: Bridging the Gap in Minimally Invasive Care

The latest statistics indicate that the application of robotic-assisted surgical methods is still relatively low across various regions, highlighting a crucial opportunity to provide advanced surgical care to more patients, surgeons, and healthcare systems worldwide. The partnership aspires to address this gap with a shared vision to elevate the standards of surgical care, leveraging Cornerstone's innovative technologies alongside Medtronic's expansive global presence.

Cornerstone Robotics has built a robust foundation through extensive internal research and development (R&D), utilizing a vertically integrated model. The company retains significant control over its core hardware, software, algorithms, imaging, and energy platforms, ensuring quality, efficiency, and reliability in delivering its Sentire™ surgical system. The system's success in challenging clinical environments indicates a substantial leap forward in precision medicine.

In recent milestones, the Sentire system received approval from China’s National Medical Products Administration in 2024, followed by CE marking in the European Union in May 2026, and clearance from the Health Sciences Authority in Singapore. This marks a significant achievement for their minimally invasive general, gynecological, thoracic, and urological procedures.

A Leap Towards Surgical Innovation

Professor Kwok Wai Samuel AU, founder and CEO of Cornerstone Robotics, emphasized the importance of this partnership by stating, “This agreement is a significant step toward improving access to robotic surgical care globally. The disparity between the rising demand for minimally invasive surgery and the availability of robotic solutions remains substantial. Our advancements in surgical robotics technology are key to bridging that gap.”

Meanwhile, Matt Anderson, Senior Vice President and President of the Surgical Division at Medtronic, noted that the investment and distribution partnership will bolster Medtronic’s mission to provide more patients with minimally invasive surgical options. The Sentire system is an excellent addition to Medtronic's Hugo™ platform, which is designed to enhance surgical treatment efficiency.

Collaboration for a Healthier Tomorrow

The partnership between Cornerstone Robotics and Medtronic represents a milestone towards making robotic-assisted surgery more accessible to patients globally. Both companies are dedicated to engineering better healthcare solutions that maintain patient safety and improve outcomes for healthcare systems around the world.

Advisors for the partnership include Kirkland & Ellis and Global Law Office serving as legal representatives for Cornerstone Robotics, while Morgan Stanley & Co. LLC acts as the exclusive financial advisor to Medtronic, with Cleary Gottlieb Steen & Hamilton LLP as the principal legal representative.

About Cornerstone Robotics

Founded in Hong Kong, Cornerstone Robotics focuses on pioneering advancements in surgical robotics with a mission of providing cutting-edge healthcare solutions that maximize efficiency in surgical practices. The company operates three global R&D centers and six commercial offices worldwide, complemented by a state-of-the-art manufacturing facility in China spanning 30,000 square meters. Their proprietary Sentire™ surgical system has undergone extensive multi-specialty clinical trials, receiving market approvals across various countries to support high-quality surgical care.

For more information about Cornerstone Robotics and their innovations, visit their website or follow them on LinkedIn.

About Medtronic

Medtronic plc, headquartered in Galway, Ireland, is a leading global healthcare technology company that boldly tackles the toughest health challenges. With a team of more than 95,000 people across over 150 countries, Medtronic’s technologies and therapies address 70 medical conditions, including cardiovascular devices, surgical robotics, insulin pumps, surgical instruments, patient monitoring systems, and more. The company’s goal is to alleviate pain, restore health, and extend life by delivering innovative technology that enhances patient outcomes every day.

To explore their solutions and advancements further, visit Medtronic's website or connect with them on LinkedIn.